pI: 5.2147 |
Length (AA): 1595 |
MW (Da): 181433 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130581)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG34124 | CG34124 gene product from transcript CG34124-RA |
Echinococcus granulosus | EgrG_000880900 | WD repeat containing protein 52 |
Echinococcus multilocularis | EmuJ_000880900 | WD repeat containing protein 52 |
Giardia lamblia | GL50803_42000 | Coiled-coil protein |
Homo sapiens | ENSG00000206530 | cilia and flagella associated protein 44 |
Leishmania braziliensis | LbrM.14.1620 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_141530.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.14.1530 | hypothetical protein, conserved |
Leishmania major | LmjF.14.1430 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.14.1430 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000071550 | cilia and flagella associated protein 44 |
Neospora caninum | NCLIV_062990 | hypothetical protein |
Neospora caninum | NCLIV_063000 | Coiled-coil protein, related |
Schistosoma japonicum | Sjp_0112620 | Conserved hypothetical protein |
Schistosoma japonicum | Sjp_0004160 | Conserved hypothetical protein |
Schistosoma japonicum | Sjp_0114340 | IPR011046,WD40-like,domain-containing |
Schistosoma japonicum | Sjp_0004150 | Conserved hypothetical protein |
Schistosoma mansoni | Smp_170710 | Protein C10orf118 (CTCL tumor antigen HD-CL-01/L14-2) |
Schistosoma mansoni | Smp_170700 | hypothetical protein |
Schmidtea mediterranea | mk4.005538.02 | Putative wd-repeat protein |
Trypanosoma brucei gambiense | Tbg972.7.3940 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.7.3560 | Component of motile flagella 7 |
Trypanosoma congolense | TcIL3000_7_2800 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509939.19 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506441.10 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508265.110 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_423210 | WD-repeat protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.3560 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.3560 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.3560 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.3560 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.